Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$696M |
| 2 |
Moderna
MRNA
|
+$487M |
| 3 |
Analog Devices
ADI
|
+$272M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$261M |
| 5 |
Tesla
TSLA
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$670M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$335M |
| 4 |
Alibaba
BABA
|
+$323M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Healthcare | 13.43% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Coursera
COUR
$1.53B
| $7.55M | ﹤0.01% |
238,603
+196,750
| +470% | +$7.41M |
|
|
RVNC
2277
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.54M | ﹤0.01% |
270,553
+19,775
| +8% | +$564K |
|
2278
TriMas Corp
TRS
$1.4B
| $7.52M | ﹤0.01% |
232,519
+12,800
| +6% | +$395K |
|
|
SRDX
2279
DELISTED
Surmodics
SRDX
| $7.48M | ﹤0.01% |
134,560
+8,330
| +7% | +$463K |
|
|
NXGN
2280
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $7.48M | ﹤0.01% |
530,458
-1,269
| -0.2% | -$19.7K |
|
2281
Orthofix Medical
OFIX
$421M
| $7.46M | ﹤0.01% |
195,762
+5,208
| +3% | +$207K |
|
|
SHOE
2282
Shoe Station Group
SHOE
$414M
| $7.44M | ﹤0.01% |
229,501
+2,741
| +1% | +$95.6K |
|
2283
Grupo Aeroportuario del Sureste
ASR
$7.94B
| $7.44M | ﹤0.01% |
39,782
+400
| +1% | +$72.3K |
|
|
HAYN
2284
DELISTED
Haynes International, Inc.
HAYN
| $7.43M | ﹤0.01% |
199,580
+4,329
| +2% | +$161K |
|
2285
Ennis
EBF
$559M
| $7.42M | ﹤0.01% |
393,399
+2,280
| +0.6% | +$44.7K |
|
|
CMO
2286
DELISTED
Capstead Mortgage Corp.
CMO
| $7.42M | ﹤0.01% |
1,108,438
+52,057
| +5% | +$341K |
|
2287
Relay Therapeutics
RLAY
$4.35B
| $7.41M | ﹤0.01% |
234,882
+67,509
| +40% | +$2.27M |
|
2288
Inogen
INGN
$153M
| $7.4M | ﹤0.01% |
171,634
+10,534
| +7% | +$648K |
|
2289
OptimizeRx
OPRX
$164M
| $7.39M | ﹤0.01% |
86,369
+40,783
| +89% | +$2.56M |
|
|
SWTX
2290
DELISTED
SpringWorks Therapeutics
SWTX
| $7.38M | ﹤0.01% |
116,356
+7,360
| +7% | +$567K |
|
2291
Revolution Medicines
RVMD
$43.7B
| $7.38M | ﹤0.01% |
268,215
+35,981
| +15% | +$1.05M |
|
|
COWN
2292
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $7.37M | ﹤0.01% |
214,868
-5,122
| -2% | -$192K |
|
|
FSR
2293
DELISTED
Fisker Inc.
FSR
| $7.36M | ﹤0.01% |
502,058
+47,554
| +10% | +$716K |
|
2294
Clearwater Paper
CLW
$345M
| $7.35M | ﹤0.01% |
191,726
+6,179
| +3% | +$196K |
|
2295
Nabors Industries
NBR
$1.39B
| $7.34M | ﹤0.01% |
76,132
+1,851
| +2% | +$161K |
|
2296
Hackett Group
HCKT
$265M
| $7.33M | ﹤0.01% |
373,377
+7,978
| +2% | +$149K |
|
2297
Vanguard Information Technology ETF
VGT
$150B
| $7.31M | ﹤0.01% |
145,728
-6,072
| -4% | -$315K |
|
2298
American Well
AMWL
$212M
| $7.31M | ﹤0.01% |
40,116
+7,540
| +23% | +$1.64M |
|
2299
Collegium Pharmaceutical
COLL
$875M
| $7.28M | ﹤0.01% |
368,827
+5,345
| +1% | +$116K |
|
|
JAMF
2300
DELISTED
Jamf
JAMF
| $7.27M | ﹤0.01% |
188,711
+16,580
| +10% | +$569K |
|
Similar funds
Bank of New York Mellon's Q3 2021 Portfolio in Review
As of Q3 2021, Bank of New York Mellon held 4,634 positions worth $512B, down 0.89% from $517B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of New York Mellon's Q3 2021 filing shows 243 new, 2,575 increased, 1,388 reduced and 114 closed positions. Its largest new stake was GXO Logistics: 863,863 shares worth $67.8M. The largest sale was Apple, an estimated $670M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2021 buy was GXO Logistics: 863,863 shares worth $67.8M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $696M increase.
- Bank of New York Mellon's biggest Q3 2021 reduction was Apple, cutting an estimated $670M.
- Bank of New York Mellon fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $335M.
- Bank of New York Mellon's ten largest holdings make up 20% of its $512B portfolio in Q3 2021.
- Bank of New York Mellon opened 243 new positions and closed 114 in Q3 2021.
- Bank of New York Mellon's portfolio value fell 0.89% quarter-over-quarter to $512B.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.